Stop Guessing. Start Targeting
Because your cancer is as unique as your DNA, your treatment should be too.
Precision insights that complement standard oncology care to guide next-step planning and ongoing monitoring.
Why do I need this test if I already have a diagnosis?
Standard oncology often treats cancer based on where it started (the organ). But two people with lung cancer can have completely different biological drivers. Without a Personalised Cancer Plan, you are essentially fighting an invisible enemy. Our testing removes the blindfold, allowing your medical team to see exactly which ‘locks’ your cancer uses, so we can find the right ‘key’ to stop it.
What is Personalised Cancer Care
A Personalised Cancer Plan combines standard mainstream treatments with precision medicine to guide intelligent and individualized treatments.
In a published study, researchers observed encouraging results for patients receiving precision oncology compared with standard care.
In a published study comparing matched vs non-matched approaches:1,2
- Median overall survival: 11.4 vs 8.6 months
- Time without progression: 4.0 vs 2.8 months
- Tumor response observed in 27% vs 5% of patients
- Disease control reported in 70% vs 27%
Matching treatment to a patient’s cancer profile may be associated with more favorable outcomes.
Median overall survival (Months)1,2
months
months
therapy
therapy
Median progression-free survival (months)1,2
months
months
therapy
therapy
- Overall survival improved from 25.8 to 51.7 weeks
- Progression-free survival increased from 12.0 to 22.9 weeks
- Late-stage survival extended from approximately 6 months to over 15 months
- Disease control achieved in 41% of patients
Impact of Precision Oncology
Supporting clearer, more informed treatment decisions
Cancer treatment involves many important decisions guided by clinical evaluation, imaging, pathology, and established medical guidelines.
Advances in precision medicine allow doctors to understand cancer at a biological level, adding insight that may support treatment planning and monitoring.
To the family member searching for answers tonight..
Contact our Professional Team for Liquid Biopsy
What is your benefit?
To support improved treatment outcomes by helping identify treatments that may be more effective for your specific cancer — while helping minimise unnecessary side effects from less effective treatments.
A Personalised Cancer Plan
(CTCs) analysis
(ctDNA) profiling
| No. | Study Title | Year | Key Findings (Simplified) | Clinical Relevance |
|---|---|---|---|---|
| 1 |
Longer survival with precision medicine in late-stage cancer patients
View study
|
2025 | Targeted therapy group lived 15.7 months vs 5–6 months without targeted selection; 44% showed meaningful benefit. | Suggests improved survival in selected late-stage cases when treatment is biologically matched. |
| 2 |
Benefits of precision medicine in lung cancer: experience from a single institution
View study
|
2022 | Early detection improved by 30%; rare mutation patients achieved up to 21 months OS/PFS with specific targeted drugs. | Demonstrates the value of molecular profiling in improving early diagnosis and treatment selection. |
| 3 |
Impact of Precision Medicine on Clinical Outcomes: A Single-Institution Retrospective Study
View study
|
2021 | 23% tumour shrinkage; 41% disease control rate; average overall survival approximately 10 months. | Indicates enhanced disease control when treatment decisions incorporate additional biological data. |
| 4 |
Precision oncology in advanced cancer improves overall survival with lower weekly healthcare costs
View study
|
2018 | Overall survival 52 weeks vs 26 weeks; progression-free survival 23 vs 12 weeks. | Suggests survival benefit and potential cost efficiency in selected advanced cancer populations. |
| 5 |
Retrospective analysis of precision medicine outcomes in advanced cancer patients
View study
|
2016 | Progression-free survival 23 vs 12 weeks without increased healthcare costs. | Shows improved time without disease worsening when therapy is guided by tumour profiling. |
Contact our Professional Team for Liquid Biopsy
What is your benefit?
To support improved treatment outcomes by helping identify treatments that may be more effective for your specific cancer — while helping minimise unnecessary side effects from less effective treatments.
Contact Us
Contact Us for the updated information on Precision Medicine
+852 4750 3485
Email Us
info@mycancerinfo.org